LYRA vs MTCH · rev $1.5M vs P/E 13, rev $1.72B
Lyra Therapeutics Inc (LYRA) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
Latest reported MTCH revenue for 2026-06-30 was $1.72B. Net income was $337.4M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
LYRA currently screens at market cap $14.4M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the LYRA and MTCH stock pages for the full models.
Not investment advice.